Results 181 to 190 of about 482,990 (203)

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Nassim Hammoudi, V Olivier Mallet   +2 more
exaly  

Immune responses and immunopathology in acute and chronic viral hepatitis

Nature Reviews Immunology, 2016
Eui-Cheol Shin, Pil Soo Sung, Su-Hyung Park   +2 more
exaly  

Self-management: Enabling and empowering patients living with cancer as a chronic illness

Ca-A Cancer Journal for Clinicians, 2011
Ruth McCorkle, Elizabeth Ercolano, Mark Lazenby   +2 more
exaly  

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

Lancet, The, 2015
Johannes Horn, Gerard Krause
exaly  

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Hakan SentÜrk, Yilmaz Cakaloglu   +2 more
exaly  

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Lancet, The, 2013
Patrick Marcellin, Edward Gane, Maria Buti   +2 more
exaly  

Chronic hepatitis B virus infection

Lancet, The, 2018
Seto Wk, Jean Michel Pawlotsky, Man-Fung Yuen   +2 more
exaly  

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

Lancet, The, 2015
David Roth, Annette Bruchfeld, AnnMarie Liapakis   +2 more
exaly  

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Lancet, The, 1997
Pierre Bedossa, T Poynard
exaly  

Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

Lancet, The, 1998
Anders Sönnerborg
exaly